Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Buy

Exponential Moving Average

Buy

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

KalVista Pharmaceuticals, Inc. Common Stock (KALV)

Pharmaceutical Preparations

https://www.kalvista.com

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States.

55 CAMBRIDGE PARKWAY, SUITE 901E
CAMBRIDGE, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/09/2015

Market Cap

536,759,136

Shares Outstanding

34,560,000

Weighted SO

34,558,709

Total Employees

N/A

Upcoming Earnings

09/05/2024

Similar Tickers

CRNX --.--%

THRX --.--%

KURA --.--%

VRDN --.--%

REPL --.--%

NVCT --.--%

LYRA --.--%

KRON --.--%

GOSS --.--%

Beta

0.9080

Last Div

0.0000

Range

7.21-16.88

Chg

-0.2300

Avg Vol

326762

Mkt Cap

536759136

Exch

NASDAQ

Country

US

Phone

857 999 0075

DCF Diff

12.1248

DCF

0.6652

Div Yield

0.0000

P/S

445.0739

EV Multiple

-3.6912

P/FV

2.6503

Div Yield %

0.0000

P/E

-4.3231

PEG

0.1524

Payout

0.0000

Current Ratio

9.8956

Quick Ratio

9.8956

Cash Ratio

1.3938

DSO

3290.1451

DIO

0.0000

Op Cycle

3290.1451

DPO

4043.8625

CCC

-753.7174

Gross Margin

0.3184

Op Margin

-116.4552

Pretax Margin

-105.0124

Net Margin

-105.0124

Eff Tax Rate

0.0000

ROA

-0.5380

ROE

-0.9228

ROCE

-0.6606

NI/EBT

1.0000

EBT/EBIT

0.9017

EBIT/Rev

-116.4552

Debt Ratio

0.0311

D/E

0.0354

LT Debt/Cap

0.0283

Total Debt/Cap

0.0342

Int Coverage

0.0000

CF/Debt

-12.1950

Equity Multi

1.1395

Rec Turnover

0.1109

Pay Turnover

0.0903

Inv Turnover

0.0000

FA Turnover

0.1318

Asset Turnover

0.0051

OCF/Share

-2.0470

FCF/Share

-2.0618

Cash/Share

4.8267

OCF/Sales

-73.9892

FCF/OCF

1.0072

CF Coverage

-12.1950

ST Coverage

-68.5338

CapEx Coverage

-138.1285

Div&CapEx Cov

-138.1285

P/BV

2.6503

P/B

2.6503

P/S

445.0739

P/E

-4.3231

P/FCF

-5.9722

P/OCF

-6.1357

P/CF

-6.1357

PEG

0.1524

P/S

445.0739

EV Multiple

-3.6912

P/FV

2.6503

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation